Atossa Capital Surpluse from 2010 to 2024
| ATOS Stock | USD 1.28 0.06 4.92% |
Capital Surpluse | First Reported 2012-09-30 | Previous Quarter 252.9 M | Current Value 254.5 M | Quarterly Volatility 81.5 M |
Check Atossa Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atossa Genetics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 21.9 K, Interest Expense of 8.7 K or Selling General Administrative of 8.7 M, as well as many indicators such as Price To Sales Ratio of 7.6 K, Dividend Yield of 0.0 or PTB Ratio of 1.16. Atossa financial statements analysis is a perfect complement when working with Atossa Genetics Valuation or Volatility modules.
Atossa | Capital Surpluse |
Latest Atossa Genetics' Capital Surpluse Growth Pattern
Below is the plot of the Capital Surpluse of Atossa Genetics over the last few years. It is Atossa Genetics' Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Atossa Genetics' overall financial position and show how it may be relating to other accounts over time.
| Capital Surpluse | 10 Years Trend |
|
Capital Surpluse |
| Timeline |
Atossa Capital Surpluse Regression Statistics
| Arithmetic Mean | 115,101,182 | |
| Geometric Mean | 72,695,935 | |
| Coefficient Of Variation | 90.44 | |
| Mean Deviation | 85,805,544 | |
| Median | 71,887,674 | |
| Standard Deviation | 104,100,461 | |
| Sample Variance | 10836.9T | |
| Range | 288.6M | |
| R-Value | 0.93 | |
| Mean Square Error | 1596.8T | |
| R-Squared | 0.86 | |
| Slope | 21,626,607 | |
| Total Sum of Squares | 151716.7T |
Atossa Capital Surpluse History
About Atossa Genetics Financial Statements
Atossa Genetics shareholders use historical fundamental indicators, such as Capital Surpluse, to determine how well the company is positioned to perform in the future. Although Atossa Genetics investors may analyze each financial statement separately, they are all interrelated. The changes in Atossa Genetics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Atossa Genetics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Capital Surpluse | 289.1 M | 303.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Atossa Stock Analysis
When running Atossa Genetics' price analysis, check to measure Atossa Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atossa Genetics is operating at the current time. Most of Atossa Genetics' value examination focuses on studying past and present price action to predict the probability of Atossa Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atossa Genetics' price. Additionally, you may evaluate how the addition of Atossa Genetics to your portfolios can decrease your overall portfolio volatility.